Non-keratinizing sinonasal squamous cell carcinoma
MONDO:0002831A squamous cell carcinoma of the sinonasal tract characterized by a plexiform or ribbon-like growth pattern, cytological atypia, and lack of histological evidence of keratinization.
Also known as: non-keratinizing sinonasal squamous cell carcinoma, Ringertz carcinoma, Schneiderian carcinoma, Sinonasal Schneiderian carcinoma, Sinonasal cylindrical cell carcinoma, Sinonasal transitional cell carcinoma, sinonasal squamous cell carcinoma
2853 clinical trials for this condition and its sub-types, 5 tagged with Non-keratinizing sinonasal squamous cell carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Immunotherapy boost before surgery may improve sinonasal cancer outcomes
Disease control Recruiting nowThis phase 2 trial tests whether adding the immunotherapy drug cemiplimab to standard chemotherapy before surgery helps people with sinonasal squamous cell carcinoma. About 108 participants will be randomly assigned to receive either chemo alone or chemo plus cemiplimab before th…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New combo treatment may spare head and neck cancer patients from disfiguring surgery
Disease control Recruiting nowThis study tests giving chemotherapy and immunotherapy before standard surgery for head and neck cancer. The goal is to shrink tumors enough so that surgeons can perform less extensive, function-preserving operations, reducing damage to swallowing, speech, and vision. The trial e…
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Personalized vaccine takes on head and neck cancer in early trial
Disease control Recruiting nowThis early-phase trial tests a personalized vaccine made from a patient's own tumor cells, given alone or with the immunotherapy drug pembrolizumab, for people with head and neck cancer that has returned or spread. The main goals are to check safety, find the best dose, and see i…
Phase 1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC